Use of pifithrin to inhibit p53-mediated signalling of TNF in dystrophic muscles of mdx mice

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11010-009-0291-2PMID 19859789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activated p53 induces NF-kappaB DNA binding but suppresses its transcriptional activation.

  2008cited by this paper
• Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions

  2008cited by this paper
• Special Topic: NF-κB, Immunity and Cancer Skeletal Muscle Diseases, Inflammation, and NF-κB Signaling: Insights and Opportunities for Therapeutic Intervention

  2008cited by this paper
• Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.

  2008cited by this paper
• IMPLICATIONS OF CROSS‐TALK BETWEEN TUMOUR NECROSIS FACTOR AND INSULIN‐LIKE GROWTH FACTOR‐1 SIGNALLING IN SKELETAL MUSCLE

  2008cited by this paper
• Protein–DNA array-based identification of transcription factor activities differentially regulated in skeletal muscle of normal and dystrophin-deficient mdx mice

  2008influential reference
• Proceedings of the Australian Physiological Society Symposium: Myopathies and Muscle Regeneration IMPLICATIONS OF CROSS-TALK BETWEEN TUMOUR NECROSIS FACTOR AND INSULIN-LIKE GROWTH FACTOR-1 SIGNALLING IN SKELETAL MUSCLE

  2008cited by this paper
• Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy.

  2008cited by this paper
• Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions.

  2007cited by this paper
• p53 and NF-?B Crosstalk: IKKa Tips the Balance

  2007cited by this paper
• p53 and NF-kappaB crosstalk: IKKalpha tips the balance.

  2007cited by this paper
• How TNF was recognized as a key mechanism of disease.

  2007cited by this paper
• Role of tumour necrosis factor α, but not of cyclo‐oxygenase‐2‐derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach

  2007cited by this paper
• Pifithrin-alpha, an inhibitor of p53 transactivation, alters the inflammatory process and delays tendon healing following acute injury.

  2007cited by this paper
• Integrating cell-signalling pathways with NF-κB and IKK function

  2007cited by this paper
• Integrating cell-signalling pathways with NF-kappaB and IKK function.

  2007cited by this paper
• Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway.

  2006influential reference
• p53 mediates particulate matter-induced alveolar epithelial cell mitochondria-regulated apoptosis.

  2006cited by this paper
• Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice.

  2006cited by this paper
• Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.

  2006cited by this paper
• Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation

  2006cited by this paper
• Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism.

  2006cited by this paper
• Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice.

  2006cited by this paper
• Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice.

  2006cited by this paper
• Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.

  2006cited by this paper
• Persistent and improved functional gain in mdx dystrophic mice after treatment with L‐arginine and deflazacort

  2006cited by this paper
• MUSCLE DAMAGE IN MDX (DYSTROPHIC) MICE: ROLE OF CALCIUM AND REACTIVE OXYGEN SPECIES

  2006cited by this paper
• Therapeutics in Duchenne muscular dystrophy

  2006cited by this paper
• IFN-gamma prevents TNF-alpha-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-kappaB activity.

  2005cited by this paper
• Inflammatory processes in muscle injury and repair.

  2005cited by this paper
• Molecular Pathogenesis of Genetic and Inherited Diseases A Multidisciplinary Evaluation of the Effectiveness of Cyclosporine A in Dystrophic Mdx Mice

  2005cited by this paper
• Prospective therapeutic applications of p53 inhibitors.

  2005cited by this paper
• Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.

  2005cited by this paper
• Novel cyclized Pifithrin-alpha p53 inactivators: synthesis and biological studies.

  2005cited by this paper
• The p53 inhibitor pifithrin-alpha forms a sparingly soluble derivative via intramolecular cyclization under physiological conditions.

  2005cited by this paper
• Inhibitors of apoptosis in lymphocytes: synthesis and biological evaluation of compounds related to pifithrin-alpha.

  2005cited by this paper
• Novel cyclized Pifithrin-α p53 inactivators: synthesis and biological studies

  2005cited by this paper
• IFN-γ prevents TNF-α-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-κB activity

  2005cited by this paper
• Anti‐TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosis

  2004cited by this paper
• Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals.

  2004cited by this paper
• Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2-4 April 2004, Naarden, The Netherlands.

  2004cited by this paper
• The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.

  2004cited by this paper
• Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.

  2004cited by this paper
• Administration of the non-steroidal anti-inflammatory drug ibuprofen increases macrophage concentrations but reduces necrosis during modified muscle use

  2003cited by this paper
• Inhibition of p53, p21 and Bax by pifithrin-alpha does not affect UV induced apoptotic response in CS-B cells.

  2003cited by this paper
• Inhibition of p53 protects liver tissue against endotoxin‐induced apoptotic and necrotic cell death

  2003cited by this paper
• The signaling adaptors and pathways activated by TNF superfamily.

  2003cited by this paper
• Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.

  2003cited by this paper
• Accumulation of an inactive form of p53 protein in cells treated with TNFα

  2002cited by this paper
• The dystrophin-associated protein complex.

  2002cited by this paper
• Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments.

  2002cited by this paper
• TNFα inhibits skeletal myogenesis through a PW1‐dependent pathway by recruitment of caspase pathways

  2002cited by this paper
• A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice.

  2002cited by this paper
• The muscular dystrophies.

  2002cited by this paper
• Do immune cells promote the pathology of dystrophin-deficient myopathies?

  2001cited by this paper
• Post-translational modifications and activation of p53 by genotoxic stresses.

  2001cited by this paper
• Insulin‐like growth factors (IGF‐I and IGF‐II) inhibit C2 skeletal myoblast differentiation and enhance TNFα‐induced apoptosis

  2001cited by this paper
• A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice

  2001cited by this paper
• Paxillin: a focal adhesion-associated adaptor protein

  2001cited by this paper
• Suppression of p53: a new approach to overcome side effects of antitumor therapy.

  2000cited by this paper
• Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts.

  2000cited by this paper
• Tumor necrosis factor‐α–induced apoptosis is associated with suppression of insulin‐like growth factor binding protein‐5 secretion in differentiating murine skeletal myoblasts

  2000cited by this paper
• A sensitive assay of tumor necrosis factor alpha in sera from Duchenne muscular dystrophy patients.

  2000cited by this paper
• A Sensitive Assay of Tumor Necrosis Factor α in Sera from Duchenne Muscular Dystrophy Patients

  2000cited by this paper
• A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.

  1999influential reference
• The effect of age and temperature on MDX muscle fatigue

  1998cited by this paper
• Interference with p53 protein inhibits hematopoietic and muscle differentiation

  1996cited by this paper
• Effect of voluntary wheel-running exercise on muscles of the mdx mouse.

  1995cited by this paper
• Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD

  1995cited by this paper
• Voluntary exercise decreases progression of muscular dystrophy in diaphragm of mdx mice.

  1994cited by this paper
• Dystrophin protects the sarcolemma from stresses developed during muscle contraction.

  1993cited by this paper
• Myogenic programs of mouse muscle cell lines: expression of myosin heavy chain isoforms, MyoD1, and myogenin

  1990cited by this paper
• Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

  1987cited by this paper
• X chromosome-linked muscular dystrophy (mdx) in the mouse.

  1984influential reference
• Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle

  1977cited by this paper

• Transcriptomic analysis of paired healthy human skeletal muscles to identify modulators of disease severity in DMD

  2023cites this paper
• Fiber optic Raman spectroscopy for the evaluation of disease state in Duchenne muscular dystrophy: An assessment using the mdx model and human muscle

  2022cites this paper
• Novel quinuclidinone derivatives induced apoptosis in human breast cancer via targeting p53.

  2017cites this paper
• The p53 inhibitor, pifithrin-α, disrupts microtubule organization, arrests growth, and induces polyploidy in the rainbow trout gill cell line, RTgill-W1.

  2016cites this paper
• Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice

  2016cites this paper
• Use of rainbow trout cell lines to delineate the roles of p53 in fish and to evaluate the toxicity of emerging environmental contaminants, benzotriazoles and benzothiazoles

  2015cites this paper
• Metformin limits ceramide-induced senescence in C2C12 myoblasts.

  2013cites this paper
• TNF-alpha in an Overuse Muscle Model-Relationship to Muscle Fiber Necrosis/Regeneration, the NK-1 Receptor and an Occurrence of Bilateral Involvement

  2013cites this paper
• p53-PGC-1α Pathway Mediates Oxidative Mitochondrial Damage and Cardiomyocyte Necrosis Induced by Monoamine Oxidase-A Upregulation: Role in Chronic Left Ventricular Dysfunction in Mice

  2013cites this paper
• Pro-apoptotic Effect of Pifithrin-α on Preimplantation Porcine In vitro Fertilized Embryo Development

  2012cites this paper
• Voluntary wheel running in dystrophin-deficient (mdx) mice: Relationships between exercise parameters and exacerbation of the dystrophic phenotype

  2012cites this paper
• PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.

  2012cites this paper
• Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells

  2011cites this paper
• Voluntary wheel running in dystrophin-deficient (mdx) mice: Relationships between exercise parameters and exacerbation of the dystrophic phenotype.

  2011cites this paper
• Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK

  2011cites this paper
• Voluntary wheel running in dystrophin-deficient (mdx) mice: Relationships between exercise parameters and exacerbation of the dystrophic phenotype.

  2011cites this paper
• Synthesis and biological evaluation of imidazolo[2,1-b]benzothiazole derivatives, as potential p53 inhibitors.

  2011cites this paper
• Eicosapentaenoic acid decreases TNF-α and protects dystrophic muscles of mdx mice from degeneration.

  2011influential citation
• Australia and New Zealand Society for Cell and Developmental Biology

  2010cites this paper